 |
 |
 |
 |
|
 |
Treatment Next 25
|
 |
Location |
 |
Last Updated |
 |
 |
 |
Details |
 |
Study of a Retroviral Replicating Vector to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor (Toca 511) |
 |
Los Angeles, CA Detroit, MI Edison, NJ Columbus, OH Seattle, WA |
 |
02/01/2012 |
 |
 |
 |
 |
 |
Details |
 |
A Study of PD 0332991 in Patients With Recurrent Rb Positive Glioblastoma |
 |
San Francisco, CA |
 |
05/04/2011 |
 |
 |
 |
Details |
 |
A Phase I Study of Peptide Vaccination With Tumor Associated Antigens Mixed With Montanide ISA-51VG in Pediatric Patients With Recurrent or Refractory Central Nervous System Tumors |
 |
New York, NY |
 |
03/10/2011 |
 |
 |
 |
 |
 |
Details |
 |
A Phase II Study of Gliadel, Concomitant Temozolomide and Radiation, followed by Dose Dense Therapy with Temozolomide Plus Bevacizumab (Avastin) for Newly Diagnosed Malignant High Grade Gliomas |
 |
Houston, TX |
 |
12/20/2010 |
 |
 |
 |
Details |
 |
BTTC08-01: Phase II Post-RT/TMZ Bevacizumab and Erlotinib for newly GBM without MGMT promoter methylation |
 |
Houston, TX |
 |
12/20/2010 |
 |
 |
 |
 |
 |
Details |
 |
Bevacizumab (Avastin) and Erlotinib (Tarceva) After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma |
 |
Los Angeles, CA Orlando, FL Chicago, IL Evanston, IL Charleston, SC Dallas, TX Houston, TX San Antonio, TX Seattle, WA |
 |
11/12/2010 |
 |
 |
 |
Details |
 |
A Phase 2 Study of Aminolevulinic Acid (ALA) to Enhance Visualization and Resection of Malignant Tumors of the Brain
|
 |
San Francisco, CA |
 |
11/04/2010 |
 |
 |
 |
 |
 |
Details |
 |
A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade Gliomas |
 |
Duarte, CA |
 |
10/22/2010 |
 |
 |
 |
Details |
 |
2006-0709: Phase I / II Adaptive Randomized Trial of Vorinostat, Isotretinoin and Carboplatin in Adults with Recurrent Glioblastoma Multiforme
|
 |
Houston, TX |
 |
03/30/2010 |
 |
 |
 |
 |
 |
Details |
 |
2006-0472: Phase I/II Trial of Irinotecan plus Lenalidomide in Adult Patients with Recurrent Glioblastoma Multiforme |
 |
Houston, TX |
 |
03/29/2010 |
 |
 |
 |
Details |
 |
2008-0059: Phase I/II study of sorafenib with radiation and temozolomide in newly diagnosed glioblastoma or gliosarcoma |
 |
Houston, TX |
 |
03/29/2010 |
 |
 |
 |
 |
 |
Details |
 |
2009-0651: Phase I/II adaptive randomized trial of vorinostat, erlotinib and carboplatin in adults with recurrent glioblastoma |
 |
Houston, TX |
 |
03/29/2010 |
 |
 |
 |
Details |
 |
BTTC08-01: Phase II Post-RT/TMZ Bevacizumab and Erlotinib for newly GBM without MGMT promoter methylation |
 |
Houston, TX |
 |
03/29/2010 |
 |
 |
 |
 |
 |
Details |
 |
ID01-310: Phase I Trial of Conditionally Replication-Competent Adenovirus (Delta-24-RGD4C) for recurrent malignant glioma |
 |
Houston, TX |
 |
03/29/2010 |
 |
 |
 |
Details |
 |
NABTC04-03: Phase I study of Vorinostat (SAHA) in combination with temozolomide in patiesnts with malignant gliomas |
 |
Houston, TX |
 |
03/29/2010 |
 |
 |
 |
 |
 |
Details |
 |
NABTC0701: Phase I Trial of Aflibercept (VEGF Trap)with Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients With Malignant Gliomas |
 |
Los Angeles, CA San Francisco, CA Boston, MA Durham, NC New York, NY Pittsburgh, PA Houston, TX San Antonio, TX Madison, WI |
 |
03/29/2010 |
 |
 |
 |
Details |
 |
Anti-Tumor Immunotherapy Targeted Against Cytomegalovirus in Patients With Newly-Diagnosed Glioblastoma Multiforme During Recovery From Therapeutic Temozolomide-induced Lymphopenia |
 |
Durham, NC |
 |
01/24/2010 |
 |
 |
 |
 |
 |
Details |
 |
Phase I/II Study of GP96 Heat Shock Protein-Peptide Complex Vaccine in Patients With Recurrent or Progressive High-Grade Glioma |
 |
San Francisco, CA |
 |
01/24/2010 |
 |
 |
 |
Details |
 |
A Phase II study of Bevacizumab (Avastin) plus Temodar and Tarceva during and after Radiation Therapy in patients with newly diagnosed Glioblastoma or Gliosarcoma |
 |
San Francisco, CA |
 |
01/11/2010 |
 |
 |
 |
 |
 |
Details |
 |
ABTC 04-03: A Phase I Study of Vorinostat (Suberolyanilide Hydroxamic Acid [SAHA]) in Combination with Temozolomide in Patients with Malignant Gliomas |
 |
San Francisco, CA |
 |
01/11/2010 |
 |
 |
 |
Details |
 |
Phase II Study of Gamma-Knife Radiosurgery Using Magnetic Resonance Spectroscopy for Target Definition in Patients with Recurrent Glioma |
 |
San Francisco, CA |
 |
01/11/2010 |
 |
 |
 |
 |
 |
Details |
 |
Bevacizumab, Temozolomide, and External Beam Radiation Therapy as First-Line Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma |
 |
Los Angeles, CA |
 |
12/30/2009 |
 |
 |
 |
Details |
 |
A PHASE II STUDY OF GLIADEL, CONCOMITANT TEMOZOLOMIDE AND RADIATION, FOLLOWED BY DOSE DENSE THERAPY WITH TEMOZOLOMIDE PLUS BEVACIZUMAB FOR NEWLY DIAGNOSED MALIGNANT HIGH GRADE GLIOMA |
 |
Cincinnati, OH |
 |
12/02/2009 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Clinical Trial of Patients with High-Grade Glioma Treated with Intra-arterial Carboplatin-based Chemotherapy, Randomized to Treatment with or without Delayed Intravenous Sodium Thiosulfate as a Potential Chemoprotectant against Severe Thrombocytopenia |
 |
Cincinnati, OH |
 |
12/02/2009 |
 |
 |
 |
Details |
 |
Vaccination With Lethally Irradiated Glioma Cells Mixed With GM-K562 Cells in Patients Undergoing Craniotomy For Recurrent Tumor |
 |
Boston, MA |
 |
09/06/2009 |
 |
 |
 |
 |
 |